Combined Use of Auto-Grafting and Non-Myeloablative Allografting for the Treatment of Hematologic Malignancies and Metastatic Breast Cancer
- 1 January 2002
- book chapter
- Published by Springer Nature
- Vol. 110, 101-112
- https://doi.org/10.1007/978-1-4615-0919-6_5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Nonmyeloablative Allogeneic Stem Cell Transplant Strategies and the Role of Mixed ChimerismThe Oncologist, 2000
- Mini-allografts: ongoing trials in humansBone Marrow Transplantation, 2000
- Mixed chimerism: Preclinical studies and clinical applicationsTransplantation and Cellular Therapy, 1999
- Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimenTransplantation and Cellular Therapy, 1999
- Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationThe Lancet, 1999
- Evidence of cytogenetic and molecular remission by allogeneic cells after immunosuppressive therapy aloneBritish Journal of Haematology, 1998
- Refractory Chronic Lymphocytic Leukemia Complicated by Hypercalcemia Treated with Allogeneic Bone Marrow TransplantationAmerican Journal of Clinical Oncology, 1994
- Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid LeukemiaNew England Journal of Medicine, 1994
- Severe immunodeficiency in patients treated with fludarabine monophosphateEuropean Journal of Haematology, 1993
- Purine nucleoside modulation of functions of human lymphocytesCellular Immunology, 1990